Cerebrospinal fluid cleaved-tau protein and 9-hydroxyoctadecadienoic acid concentrations in pediatric patients with hydrocephalus

Pediatric Critical Care Medicine

Volumn 9, Issue 5, 2008, Pages 524-529

  Cengiz, Pelin ^a,b   Zemlan, Frank ^c   Ellenbogen, Richard ^a   Hawkins, Douglas ^a   Zimmerman, Jerry J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b University of Wisconsin Children's Hospital   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

9 hydroxyoctadecadienoic Acid; Cerebrospinal fluid; Cleaved tau protein; Hydrocephalus; Lipid peroxidation; Neurological injury; Neuronal injury

Indexed keywords

DIMORPHECOLIC ACID; TAU PROTEIN; BIOLOGICAL MARKER; HYDROXYOCTADECADIENOIC ACID; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; AXONAL INJURY; BRAIN VENTRICLE PERITONEUM SHUNT; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID LEVEL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; FEMALE; HUMAN; HYDROCEPHALUS; INFANT; INTRACRANIAL HYPERTENSION; LIPID PEROXIDATION; MALE; NERVE CELL LESION; OBSERVATIONAL STUDY; PEDIATRIC HOSPITAL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; TERTIARY HEALTH CARE; HOSPITAL; OBSERVATION; PATHOPHYSIOLOGY;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FATTY ACIDS, UNSATURATED; FEMALE; HOSPITALS, PEDIATRIC; HUMANS; HYDROCEPHALUS; INFANT; MALE; OBSERVATION; PROSPECTIVE STUDIES; TAU PROTEINS; VENTRICULOPERITONEAL SHUNT;

EID: 60849097320     PISSN: 15297535     EISSN: None     Source Type: Journal    
DOI: 10.1097/PCC.0b013e3181849dc9     Document Type: Article

References (51)

1. Balasubramaniam J, del Bigio MR: Analysis of age-dependant alteration in the brain gene expression profile following induction of hydrocephalus in rats. Exp Neurol 2002; 173: 105-113
2. del Bigio MR: Cellular damage and prevention in childhood hydrocephalus. Brain Pathol 2004; 14:317-324
3. del Bigio MR: Neuropathological changes caused by hydrocephalus. Acta Neuropathol 1993; 85:573-585
4. Goh D, Minns RA: Intracranial pressure and cerebral arterial flow velocity indices in childhood hydrocephalus: Current review. Childs Nerv Syst 1995; 11:392-396
5. Caner H, Atasever A, Kilinc K, et al: Lipid peroxide level increase in experimental hy-drocephalus. Acta Neurochir 1993; 121: 68-71
6. Radwanska-Wala B, Buszman E, Bafeltowska J, et al: The effect of netilmicin and vanco-mycin on lipid peroxidation processes in ce-rebrospinal fluid in children with hydroceph-alus. Pathol Res Pract 2002; 198:421-423
7. Barnes NP, Jones SJ, Hayward RD, et al: Ventriculoperitoneal shunt block: What are the best predictive clinical indicators? Arch Dis Child 2002; 87:198-201
8. Iskandar BJ, McLaughlin C, Mapstone TB, et al: Pittfalls in the diagnosis of ventricular shunt dysfunction: Radiology reports and ventricular size. Pediatrics 1998; 101: 1031-1036
9. Nussinovitch M, Volovitz B, Finkelstein Y, et al: Lactic dehydrogenase isoenzymes in cere-brospinal fluid associated with hydrocepha-lus. Acta Paediatr 2001; 90:972-974
10. Beems T, Simons KS, van Geel WJA, et al: Serum- and CSF- concentrations of brain specific proteins in hydrocephalus. Acta Neu-rochir (Wien) 2003; 145:37-43
11. Koehne P, Hochhaus F, Felderhoff-Mueser U, et al: Vascular endothelial growth factor and erythropoietin concentrations in cerebrospi-nal fluid of children with hydrocephalus. Childs Nerv Syst 2002; 18:137-141
12. Felderhoff-Muesser U, Herold R, Hochhaus F, et al: Increased cerebrospinal fluid concentrations of soluble Fas (CD95/Apo-1) in hydrocephalus. Arch Dis Child 2001; 84: 369-372
13. Hochhaus F, Koehne P, Schäfer C, et al: Elevated nerve growth factor and neuro-tropin-3 levels in cerebrospinal fluid of children with hydrocephalus. BMC Pediatr 2001; 1:2
14. Onodera Y, Kawaguchi T, Ito H: Fatty acid of cerebrospinal fluid in arrested hydrocepha-lus. Childs Brain 1982; 9:95-101
15. Onodera Y, Ito H: Fatty acid in cerebrospinal fluid of congenital hydrocephalus. Childs Brain 1977; 3:101-108
16. Kosik KS, Finch EA: MAP2 and tau segregate into dendritic and axonal domains after the elaboration of morphologically distinct neuritis: An immunocytochemical study of cul- tured rate cerebrum. J Neurosci 1987; 7:3142-3153
17. Zemlan FP, Rosenberg WS, Luebbe P, et al: Quantification of axonal damage in traumatic brain injury: Affinity purification and characterization of cerebrospinal fluid tau proteins. J Neurochem 1999; 72:741-750
18. Zemlan FP, Jauch EC, Dickinson M, et al: Biomarker of neuronal damage: MAP-tau proteolysis in traumatic brain injured patients. Brain Res 2002; 947:131-139
19. Zemlan FP, Mulchahey JJ, Gudelsky GA: Quantification and localization of kainic acid-induced neurotoxicity employing a new biomarker of cell death: Cleaved microtu-bule-associated protein-tau (C-tau). Neuroscience 2003; 121:399-409
20. Irazuzta JE, de Courten-Myers G, Zemlan FP, et al: Serum cleaved tau protein and neu-robehavioral battery of tests as markers of brain injury in experimental bacterial meningitis. Brain Res 2001; 913:95-105
21. Irazuzta JE, Pretzlaff R, Rowin M, et al: Hypothermia as an adjunct treatment for severe bacterial meningitis in rabbits. Brain Res 2000; 881:88-97
22. Irazuzta JE, Pretzlaff RK, Zingarelli B, et al: Modulation of nuclear factor- B activation and decreased markers of neurologic injury associated with hypothermic therapy in experimental bacterial meningitis. Crit Care Med 2002; 30:2553-2559
23. Shaw GJ, Jauch EC, Zemlan FP: Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury. Ann Emerg Med 2002; 39:254-257
24. Wallace TL, Vorhees CV, Zemlan FP, et al: Methamphetamine enhances the cleavage of the cytoskeletal protein tau in the rat brain. Neuroscience 2003; 116:1063-1068
25. Gabbita PS, Scheff SW, Menard RM, et al: Cleaved-tau: A biomarker of neuronal damage after traumatic brain injury. J Neuro-trauma 2005; 22:83-94
26. Straiko MM, Gudelsky GA, Coolen LM, et al: Treatment with trimethyltin promotes the formation of cleaved tau in the rat brain. J Neurosci 2006; 84:1116-1123
27. Stoll LL, Morland MR, Spector AA: 13-HODE increases intracellular calcium in vascular smooth muscle cells. Am J Physiol 1994; 266:C990-C996
28. Camacho M, Godessart N, Anton R, et al: Interleukin-1 enhances the ability of cultured human umbilical vein endothelial cells to oxidize linoleic acid. J Biol Chem 1995; 270:17279-17286
29. Dandona P, Mohanty P, Ghanim H, et al: The suppressive effect of dietary restriction and weight loss in the obese on the generation of reactive oxygen species by leukocytes, lipid peroxidation and protein carbonylation. J Clin Endocrinol Metab 2001; 86:355-362
30. Henricks PA, Engels F, van der Vliet H, et al: 9- and 13- hydroxy-linoleic acid possess che-motactic activity for bovine and human poly-morphonuclear leukocytes. Prostaglandins 1991; 41:21-27
31. Ku G, Thomas CE, Akeson AL, et al: Induction of interleukin 1 beta expression from human peripheral monocytes-derived mac-rophages by 9-hydroxyoctadecadienoic acid. J Biol Chem 1992; 267:14183-14188
32. Tontonoz P, Nagy L, Alvarez JG, et al: PPAR promotes monocyte/macrophage differentiation and uptake of LDL. Cell 1998; 93: 241-252
33. Fischer B, Vonknethen A, Brü ne B: Dualism of oxidized lipoprotein in provoking and attenuating the oxidative burst in macro-phages: Role of peroxisome proliferator-activated receptor . J Immunol 2002; 168: 2828-2834
34. Li WG, Stoll LL, Rice JB, et al: Activation of NAD(P)H oxidase by lipid peroxides: Mechanism of oxidant-mediated smooth muscle cy-totoxicity. Free Radic Biol Med 2003; 34: 937-946
35. Inouye M, Mio T, Sumino K: Formation of 9-hydroxy linoleic acid as a product of phospholipid peroxidation in diabetic erythrocyte membranes. Biochem Biophys Acta 1999; 1438:204-212
36. Metzger K, Angres G, Maier H: Lipoxygenase products in human saliva: Patients with oral cancer compared to controls. Free Radic Biol Med 1995; 18:185-194
37. Kreil P, Spiteller G, Johannes G, et al: Strong increase of 9-hydroxy-10, 12-octadecadienoic acid in low density lipoptotein after a hemorrhagic shock. Z Naturforsch C 1998; 53: 876-882
38. del Bigio MR: Hydrocephalus-induced changes in the composition of cerebrospinal fluid. Neurosurgery 1989; 25:416-423
39. Cobbs CS, Brenman JE, Aldape KD, et al: Expression of nitricoxide synthase in human central nervous system tumors. Cancer Res 1995; 55:727-730
40. Spindler SA, Clark KS, Callewart DM, et al: Significance and immunoassay of 9- and 13-hydroxyoctadeadienoic acids. Biochem Bio-phys Res Commun 1996; 218:187-191
41. Kudo T, Mima T, Hashimoto R, et al: Tau protein is a potential biological marker of normal pressure hydrocephalus. Psychiatry Clin Neurosci 2000; 54:199-202
42. Posmantur RM, Kampfl A, Liu SJ, et al: Cy-toskeletal derangements of cortical neuronal processes three hours after traumatic brain injury in rats: An immunofluorescence study. J Neuropathol Exp Neurol 1996; 55: 68-80
43. Maxwell WL, Donnelly S, Sun X, et al: Axonal cytoskeletal responses to nondisruptive ax-onal injury and the short term effects of post-traumatic hypothermia. J Neurotrauma 1999; 16:1225-1234
44. Taft WC, Yang K, Dixon CE, et al: Microtu-bule-associated protein 2 levels decrease in hippocampus following traumatic brain injury. J Neurotrauma 1992; 9:281-290
45. Pettus EH, Povlishock JT: Characterization of a distinct set of intra-axonal ultrastruc-tural changes associated with traumatically induced alteration in axolemmal permeability. Brain Res 1996; 722:1-11
46. Bayir H, Kagan VE, Tyurina YY, et al: Assessment of antioxidant reserves and oxidative stress in cerebrospinal fluid after severe traumatic brain injury in infants and children. Pediatr Res 2002; 51:571-578
47. Hoffman SW, Moore S, Ellis EF, et al: Iso-prostanes: Free radical-generated prosta-glandins with constrictor effects on cerebral arterioles. Stroke 1997; 28:844-849
48. Illingworth DR, Glover J: The composition of lipids in cerebrospinal fluid of children and adults. J Neurochem 1971; 18:769-776
49. Tichy J, Skorkovska I, Base J: Spectrum of total fatty acids in cerebrospinal fluid determined by gas chromatography. J Chro-matogr 1979; 162:185-196
50. Spiteller G: Are lipid peroxidation processes induced by changes in the cell wall structure and how are these processes connected with diseases? Med Hypotheses 2003; 60:69-83
51. Yoshida Y, Itoh N, Hayakawa M, et al: Lipid peroxidation in mice fed a choline-deficient diet as evaluated by total hydroxyoctadecadi-enoic acid. Nutrition 2006; 22:303-311